Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A new “2 in 1” anticoagulant is isolated from a tick

20.02.2008
The discovery of a new anticoagulant with promising therapeutic value is reported on the 20th of February issue of the journal PLoS ONE1.

Boophilin – as it was named - is particularly interesting due to a capability to block thrombin – probably the most important (and difficult to inhibit) protein in blood clotting – as well as a second pro-coagulant molecule making it the first bivalent thrombin-inhibitor ever described. This specific bivalence suggests that boophilin can be a very effective anti-coagulant even at small quantities, opening the door to the development of new more specific and effective, and so also safer, blood thinning therapies.

When a blood vessel is damaged, bleeding is stopped through a series of chemical reactions that result in the injured wall being “tamponed” by platelets and a fibrillar protein called fibrin, allowing the tissues time to heal. And it is thrombin that, not only mediates the formation of fibrin from blood fibrinogen, but also activates the platelets, making it one of the most crucial enzymes (enzymes are proteins that facilitate specific chemical reactions) in coagulation.

Blood-feeding animals such as cattle ticks – which for proper feeding need to block clotting in their “feeding grounds” - produce anticoagulants, many of which target thrombin. Identification and study of these molecules has been an important area of research in the development of better anti-coagulant therapies for the millions of people at risk of blood clots, which, when untreated, can lead to life-threatening situations, such as heart attacks and strokes. Cardiovascular diseases are, after all, still the major non-accidental cause of death in the developing world

It is in this context that Sandra Macedo-Ribeiro, Pablo Fuentes-Prior, Pedro José Barbosa Pereira and colleagues, working in Portugal, Spain and Germany, looked into the salivary glands of one of the most widespread – and economically damaging – cattle tick, called Boophilus microplus. The fact that Boophilus is so successful suggested that it could be a promising source of new effective anti-coagulants.

And in fact, the researchers found boophilin, which, not only strongly inhibited thrombin but– and this was new among thrombin inhibitors – also a second pro-coagulant.

In order to understand boophilin’s inhibitory mechanism, the next step saw Macedo-Ribeiro, Fuentes-Prior, Pereira and colleagues analysing the three-dimensional crystal structure of the boophilin-thrombin complex. To their surprise, boophilin was found to be composed of two Kunitz domains, which are structural and functional elements that, although frequently found in enzyme inhibitors are, nevertheless, considered poor thrombin inhibitors.

In fact, Kunitz structures normal inhibitory mechanism consists of inserting into the enzyme’s binding centre (also called catalytic centre) a protruding loop structure that blocks its capacity to attach (and consequently affect) other molecules. But thrombin has its catalytic site located within a crevice too narrow for a Kunitz loop to enter and, as result, the only thrombin-inhibitor with a Kunitz architecture so far described – ornithodorin - needed an alternative inhibitory mechanism. Ornithodorin - which has a distorted Kunitz architecture and no loop - binds across thrombin’s catalytic site, blocking its access to any protein. In the analysis of the three-dimensional structure of the boophilin-thrombin complex it was seen that also boophilin – like ornithodorin – blocked thrombin by binding parallel across its active site. In this case, however, this left boophilin’s intact Kunitz’s loop, free to inhibit a second pro-coagulant. It is this “2 in 1” capability that makes boophilin remarkable according to Sandra Ribeiro, the paper’s first author.

The discovery of a common inhibitory mechanism between boophilin and ornithodorin is particularly interesting as the two proteins have very different sequences and the function of a protein is linked to its three-dimensional structure, which, in turn, is determined by its sequence (working as an instruction leaflet for the right protein folding).

This means that, frequently, the three-dimensional structure of a new protein, as well as its function, is deduced from looking into other proteins with similar sequences but with known 3D structure and function. What makes Macedo-Ribeiro, Fuentes-Prior, Pereira and colleagues’ results so interesting is that they clearly show that different sequences on boophilin and ornithodorin result, nevertheless, in the same mechanism of inhibition, and, as such, are an alert for the dangers of predicting a protein function from its sequence.

On the other hand, the details of the interactions between thrombin and boophilin are markedly distinct from those of thrombin-ornithodorin, this time warning against the use of known complex structures to deduce the interaction within other complexes no matter how similar their components appear to be.

But Macedo-Ribeiro, Fuentes-Prior, Pereira and colleagues’ boophilin discovery and structural characterization is also important because it can help in the development of better anti-thrombotic therapies.

Every year millions of people die from clots blocking crucial organs, despite the fact that about two percent of the world (aging) population is already on blood thinning drugs and these numbers show the importance of developing better anti-coagulant therapies. At the moment anti-coagulation drugs still have too many side effects and – because they can interact with other chemicals, including some found on food – are difficult to dosage. Too much anti-coagulant can induce haemorrhages while too little can lead to blood clots that result in thrombosis or strokes. More specific and consequently more effective, and so also safer drugs are necessary and boophilin appears to be a promising start.

Finally, to understand better the mechanisms behind molecules used by parasites such as Boophilus microplus can lead to a better comprehension on how they contribute to disease transmission (in this and other blood feeding organisms) and the discovery of pharmacologically interesting molecules, as well as possible important vaccine targets.

* GPEARI / MCTES - Gabinete de Planeamento, Estratégia, Avaliação e Relações Internacionais / Ministério da Ciência, Tecnologia e Ensino Superior

Catarina Amorim | alfa
Further information:
http://www.plosone.org/doi/pone.0001624

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Researchers invent tiny, light-powered wires to modulate brain's electrical signals

21.02.2018 | Life Sciences

The “Holy Grail” of peptide chemistry: Making peptide active agents available orally

21.02.2018 | Life Sciences

Atomic structure of ultrasound material not what anyone expected

21.02.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>